Science

T-cell study adds to debate over duration of COVID-19 immunity

By Kate Kelland

A small but key UK study has found that “cellular immunity” to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 — suggesting they might have some level of protection for at least that time.

Scientists presenting the findings, from 100 non-hospitalized COVID-19 patients in Britain, said they were “reassuring” but did not mean people cannot in rare cases be infected twice with the disease.

“While our findings cause us to be cautiously optimistic about the strength and length of immunity generated after SARS-CoV-2 infection, this is just one piece of the puzzle,” said Paul Moss, a professor of haematology at Britain’s Birmingham University who co-led the study.

“There is still a lot for us learn before we have a full understanding of how immunity to COVID-19 works.”

Experts not directly involved with the study said its findings were important and would add to a growing body of knowledge about potential protective immunity to COVID-19.

The study, which has not yet been peer-reviewed by other experts but was published online on bioRxiv, analyzed the blood of 100 patients six months after they had had either mild or asymptomatic COVID-19. It found that while some of the patients’ antibody levels had dropped, their T-cell response — another key part of the immune system — remained robust.

“(Our) early results show that T-cell responses may outlast the initial antibody response,” said Shamez Ladhani, a consultant epidemiologist at Public Health England who co-led the work.

The study also found the size of T-cell response differed, and was considerably higher in people who had had symptomatic COVID-19 than those who had no symptoms when infected.

The researchers said this could be interpreted in two ways: It is possible that higher cellular immunity might give better protection against re-infection in people who had symptoms, or equally, that asymptomatic patients are better able to fight off the virus without the need to generate a large immune response.

While more than 46 million people worldwide have been infected with COVID-19, confirmed cases of re-infection are so far very rare.

Reuters

Reuters

Recent Posts

Union II’s Unbeaten Start Ends In 3-1 Away Defeat to FC Cincinnati 2

After the senior team lost their unbeaten start to the season last night, Marlon LeBlanc…

18 mins ago

Digging into Philadelphia’s Latine community gardens

Community gardens foster a space for a sense of belonging. This is especially true for…

28 mins ago

Ranger Suarez Pitches His Way Into Phillies History With Win Over San Diego

SAN DIEGO - After a rough 2023 campaign that saw him post a 4.18 ERA…

14 hours ago

Phillies’ First West Coast Trip Starts Hot; Third Sweep in Four Series

The Phillies left Cincinnati with a series split and headed to the West Coast to…

14 hours ago

Report: Eagles to sign former Jets OT Mehki Becton

According to Adam Schefter of ESPN, the Philadelphia Eagles are signing OT Mehki Becton to…

14 hours ago

Preliminary report sheds light on Office of Homeless Services deficit

Philadelphia’s inspector general has found that the city’s homeless services office “knowingly” overspent in the…

16 hours ago

This website uses cookies.